Ms. Rachna Bakhru from our firm was recently interviewed By Asia IP Law for sharing her valuable insights on pharmaceutical patenting in India and the issues surrounding it. The informative article details out comments from leading IP practitioners in the country on Indian patent laws on pharmaceuticals. Ms. Bakhru particularly shared her expertise and views on Telemedicines Practice Guidelines which arose out of the Covid-19 situation currently grappling the world.

The complete article can be read at the following link:

https://asiaiplaw.com/section/news-analysis/pharm-corp-billionaire